Treatment
Medication clinical trials
We’re tracking 7,458 recruiting studies that include Medication, each written for real people, not researchers, below.
Recruiting studies
- NCT06460116Recruiting
Helping Teens in Southeast Kansas Attend School More
This study tests a program that uses community health workers to help teens in Southeast Kansas who have missed a lot of school. The goal is to improve attendance and health.
Kansas City, KansasAges 12 years+ - NCT06461377RecruitingPhase 4
GLP-1RA for heart nerve damage in type 2 diabetes
This trial tests whether a type of diabetes medicine called GLP-1RA can help prevent or improve nerve damage in the heart caused by diabetes. It is for people with type 2 diabetes who are overweight or obese.
Nanjing, JiangsuAges 18–70 - NCT06462092RecruitingPhase 1/Phase 2
Sacituzumab Govitecan and Spinal Chemo for Breast Cancer Spread to Spinal Fluid
This trial tests a combination of a targeted antibody-drug (sacituzumab govitecan) and chemotherapy given into the spinal fluid. It is for people with HER2-negative breast cancer that has spread to the membranes around the brain and spinal cord (leptomeningeal metastases). The goal is to see if this treatment can help control the cancer in the central nervous system.
Huizhou, GuangdongAges 18–75 - NCT06462833Recruiting
Health literacy and exercise in postmenopausal osteoporosis
This study looks at how understanding health information affects exercise and taking medicine correctly in women with osteoporosis after menopause. It aims to help improve bone health.
Ankara, YenimahalleAges 45 years+ - NCT06463704Recruiting
Infectious disease trial screening study
This study is a general screening program for people interested in participating in infectious disease research trials at Beth Israel Deaconess Medical Center. It helps researchers find the right trial for you based on your health and availability.
Boston, MassachusettsAges 18 years+ - NCT06463808Recruiting
Heart recovery after heart attack with added protein therapy
This trial tests if adding a protein called rhBNP (which helps the heart relax) to standard care after a heart attack and stent improves heart recovery and pumping strength over time.
Nanjing, JiangsuAges 18–75 - NCT06463756Recruiting
AI Predicts Thyroid Cartilage Invasion in Laryngeal Cancer
This study uses AI to analyze CT scans and predict if laryngeal cancer has spread to the thyroid cartilage. It may help doctors plan better treatment without needing extra invasive procedures.
ChongqingAges 18–81 - NCT06463847RecruitingPhase 1
Stem cell therapy for knee osteoarthritis
This trial tests a new stem cell treatment (UC-MSCs) for knee osteoarthritis. It aims to see if this treatment is safe and can help reduce pain and improve knee function.
Wuhan, HubeiAges 50–70 - NCT06463886Recruiting
HIV medication support for Black women with trauma
This study explores ways to help Black women with HIV who have experienced trauma stick with their HIV medication. It looks at whether extra support can improve viral suppression and overall health.
Miami, FloridaAges 18 years+ - NCT06464926Recruiting
Electrical stimulation for chronic nausea and vomiting
This study tests a device that sends mild electrical pulses to your stomach to help with chronic nausea and vomiting. It is for people who have had nausea for over 6 months, have normal stomach emptying, and have not found relief from standard medications.
Scottsdale, ArizonaAges 18 years+ - NCT06464952Recruiting
Prebiotics for PTSD and cirrhosis
This trial tests if a prebiotic supplement can improve gut health and PTSD symptoms in people with cirrhosis and PTSD. It aims to see if changing the gut microbiome can help both conditions.
Richmond, VirginiaAges 18 years+ - NCT06465719Recruiting
Robot-assisted surgery for moderate brain bleeding
This trial tests if a minimally invasive surgery guided by a robotic AI system can help people with moderate bleeding deep inside the brain (basal ganglia). If you qualify, the surgery would happen within 72 hours of your stroke.
Hangzhou, ZhejiangAges 18 years+ - NCT06466330Recruiting
Knee embolization for post-replacement pain
This trial tests a non-surgical treatment called microparticle geniculate artery embolization for people with persistent knee pain after a total knee replacement. It aims to reduce pain by blocking tiny blood vessels that may be causing inflammation.
CréteilAges 40–80 - NCT06466538RecruitingPhase 2/Phase 3
Boswellia vs standard medicine for root canal infection
This trial tests whether a natural gum resin (Boswellia) placed inside the tooth during root canal treatment can fight infection better than standard medications. It may be a good option for people with a single-rooted tooth infection who are otherwise healthy.
Al MansurahAges 20–60 - NCT06466850Recruiting
Stem cell exosomes for knee osteoarthritis
This trial studies whether a natural substance called exosomes, derived from stem cells, can help reduce pain and improve function in people with knee osteoarthritis. It may be an option if other treatments have not worked well for you.
IsfahanAges 45–75 - NCT06467097RecruitingPhase 3
Drug therapy vs. drug therapy plus radiation for limited kidney cancer
This trial tests whether adding radiation to standard drug therapy helps control kidney cancer that has spread to a few spots (oligometastatic). It is for people with clear cell renal cell carcinoma who have up to 5 metastases.
SeoulAges 20–80 - NCT06467617RecruitingPhase 2
Immunotherapy and chemo before and after lung cancer surgery
This trial tests a combination of an immunotherapy drug (adebrelimab) plus chemotherapy and another drug (recaticimab) before and after surgery for people with stage II or III lung cancer that can be removed. The goal is to see if this approach helps shrink tumors and improves outcomes.
Beijing, Beijing MunicipalityAges 18–75 - NCT06467708Recruiting
Ear Stimulation for ICU Patients with Traumatic Brain Injury
This study tests a very small electrical device placed on the ear to see if it can help people with traumatic brain injury recover in the intensive care unit (ICU). The device sends gentle pulses to a nerve that may calm inflammation and improve brain function.
Dallas, TexasAges 18 years+ - NCT06467864Recruiting
Predicting lung infection outcomes using early bacteria tests
This trial tests a new way to predict how well patients with a ventilator-associated lung infection will respond to treatment. It uses two bronchoscopy samples to track bacteria levels and guide better care.
Nanjing, JiangsuAges 18 years+ - NCT06469580Recruiting
Lung ultrasound to guide breathing tube removal in newborns
This study tests whether using lung ultrasound helps doctors decide the best time to remove a breathing tube from preterm and full-term newborns. It may reduce the chance of needing to put the tube back in.
Graz, StyriaAges 1 minute–6 months - NCT06472102Recruiting
Heart nerve ablation for severe fainting
This study tests a procedure called cardioneuroablation, which uses targeted heat (radiofrequency) to calm overactive nerves that cause your heart to beat too slowly and make you faint. The goal is to stop severe fainting spells in people with reflex syncope who haven't gotten better with other treatments.
Warsaw, Masovian VoivodeshipAges 14 years+ - NCT06474338Recruiting
AI detects bladder tumors during cystoscopy
This trial tests if artificial intelligence can spot bladder tumors in videos taken during a cystoscopy exam. If you are already scheduled for a cystoscopy and the video is clear, you may be able to participate.
Beijing, Beijing MunicipalityAges 18–100 - NCT06477146RecruitingPhase 2
Milk thistle for fatty liver in children and young adults
This trial tests whether milk thistle can help children and young adults with non-alcoholic fatty liver disease (NAFLD), a condition where fat builds up in the liver unrelated to alcohol use. It aims to see if the supplement can lower liver enzymes and improve liver health.
Cleveland, OhioAges 9–22 - NCT06477549RecruitingPhase 2
Comparing Two Drug Combinations for Stem Cell Transplant
This study compares two different drug combinations (BeFluBu and FluBuRux) used before a stem cell transplant from a half-matched (haploidentical) donor. The goal is to see which combination works better to prepare your body for the transplant and control your blood cancer.
Saint PetersburgAges 18–75
Common questions
- Are there clinical trials studying Medication?
- Yes. Clin2 currently lists 7,458 recruiting studies that include Medication, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Medication trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Medication an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Medication or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.